Remicade

In the US, Remicade (infliximab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Bullous Pemphigoid, Celiac Disease, Cogan's Syndrome, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Giant Cell Arteritis, Juvenile Idiopathic Arthritis, Kawasaki Disease, Neurosarcoidosis, Pemphigoid, Pemphigus, Polychondritis, Psoriasis, Psoriatic Arthritis, Pulmonary Fibrosis, Pyoderma Gangrenosum, Rheumatoid Arthritis, SAPHO Syndrome, Sarcoidosis, Sjogren's Syndrome, Subcorneal Pustular Dermatosis, Toxic Epidermal Necrolysis, Ulcerative Colitis and Uveitis.

US matches:

• Remicade

Ingredient matches for Remicade

Infliximab

Infliximab is reported as an ingredient of Remicade in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• El Salvador


• Finland


• France


• Georgia


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Thailand


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search